Get startedLog in
    Picture of Harvard Apparatus Regenerative Technology logo

    HRGN — Harvard Apparatus Regenerative Technology News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Biostage Q3 loss per share $0.18

    Picture of Harvard Apparatus Regenerative Technology logoHarvard Apparatus Regenerative Technology
    10/11/2016 12:05
    Nov 10 (Reuters) - Biostage Inc  BSTG.O : 
    * Biostage Inc - company remains on track to commence 
first-in-human study for esophageal implant in Q4 2017 
    * Biostage Inc - IND filing for esophageal implant expected 
in q3 2017 
    * Biostage reports 2016 third quarter financial results and 
provides business update 
    * Q3 loss per share $0.18 
 
Source text for Eikon:  ID:nPn3n2gJ3a  
Further company coverage:  BSTG.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

    Recent news on Harvard Apparatus Regenerative Technology

    See all news